The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I see PoorInvestor and his Merry men got excited that incoming news was due after seeing a flurry of transactions.
Is there incoming news? Not on your Nelly. No chance. No way Jose. This is EVG, don’t expect any significant updates for months.
As for PoorInvestor who had stayed awake wondering if a buy out of EVG is on the cards? No chance. No way Jose. Who the heck would buy this out at this stage? It’s burning through money faster than Boris Becker.
This is what I don't get with you, you say I talk nonsense and lack of further analysis from myself and kingalf, yet you have demonstrated this is exactly what you do, not me.
The Juv deal, I am totally aware that EVG and Juvenescense said that it was a change in business direction. So you think that is fine, that explains all and if only I had read that it would explain everything I needed to know? Really? I said I wanted to know why after 3 years of Juvenescense working on product development and spending a lot of money they decided to return the rights. There must have been a reason why they did that and that was what I wanted to know. Was it that the SFX-01 product was not showing the results they wanted? Did they feel the product would not be profitable? Why did they not include this venture in their new business direction? But of course me wanting to know further details is according to you me talking nonsense and lack of detail and analysis from me? Interesting.
As for the Stalicla delay, you say I fail to understand the complexities of pharma research. Well that's brilliant thank you for explaining. I mean my goodness, you fail to understand a simple point I made. The point I made was that EVG originally wrote - and I quote in the Half Year Report 08/12/2022 'Up to $6m in initial milestones to be received before end of 2023' changed to 'Up to $5.5m in further milestones expected within 2024' in the Final Results 07/06/2023. My point here is why did EVG write $6m to be received before end of 2023 if it was not set in stone? Why did they not write $6m anticipated or expected before end of 2023? You seem to think it is perfectly acceptable to claim something will be received by a certain date and then if it is does not happen then it is fine because it is complex. Look, don't say it if it is not guaranteed.
You seem to like being condescending in that I lost £3200 here saying it is a little amount and it surely is a small fraction of my portfolio. Maybe £3200 isn't much to you, maybe you are loaded and £3200 isn't anything to be bothered by. I invested here hoping to double my money. Yes I could afford to lose it but it was never my aim to lose £3200, I would have used that to go dining out at nice restaurants every friday for a year or go on a second holiday last year.
Share placing - I agree with Alf, if there is a share placing it will of course be between 1p and 1.5p given what the current share price is. What do you think a share placing will be at? Whether it happens we will see but even you cannot deny the fact that money is running out and without the Stalicla money they will need to issue a share placing in order to raise money to keep the company afloat.
So let me get this straight you post on Music Magpie messageboard but you are not invested there? But you are critical of people who post on this EVG messageboard who were invested and sold out? So posting on a messageboard when not invested is ok if you do it but not for others?
XxPoorinvestorxx you come on here portraying yourself as a shrewd and clued up investor, thinking you have the moral high ground dismissive of anyone who doesn’t share your views. You’re a typical liberal leftie bully, trying to cancel and censor anyone who thinks differently to you.
You seem to think you are a very good investor, your username even shows what high regard you have for yourself as an investor but look at the shares you invest in - EVG and Music Magpie and yet have the audacity to say I am clueless despite investing in big shares like Aviva and Flutter.
Your portfolio of shares is like a Benny Hill video collection.
EVG has fallen from 22p to 1.5p over the past 5 years and yet you think this is a quality share that is a strong buy.
You’re going to ultimately look very foolish when the game is up here. I’ll be looking out for you sunshine.
XxAmateurInvestorxx you seem to be very sure that EVG will receive the $5.5m this year and in time to prevent the company running out of cash in the back of the year.
I think it’s far from a certainty myself. EVG announced that they would receive $5.5m by the end of 2023 and that was changed in the full results last year to expected up to $5.5m by the end of 2024 without any explanation.
The last we heard was that EVG and Stalicla would analyse a very large and complex dataset. It sounds like any further payments will only happen once that is complete. But how long will that take? What if the results are disappointing and Stalicla pull the plug?
I don’t hold a lot of trust in what EVG tell shareholders. To say $5.5m would be received by end of 2023 which was why I bought in was a disgrace, they shouldn’t be allowed to say that unless it’s guaranteed.
They fob us off saying they can’t buy shares but won’t explain. They gave no warning of the Juvenesense deal being in trouble and did not explain why it was pulled.
If EVG do receive this money it will be excellent news and push the share price up but you’re putting your trust in EVG’s words that it’s going to be received this year, time will tell if they were trustworthy this time.
sounds like toni is a very good signing, the shareholders are very lucky to have her on board to help paddle the ship down **** creek.
There has been no news for coming up to 2 months, surely there must be something to report before the year is out?
Any news about the Stalicla payments would be useful. It’s been a thoroughly miserable year here. Started the year at 4.5p and now around 1.5p. The Stalicla payments we were told would be received by the end of 2023 changed to expected by the end of next year. Juvenesense pulled the plug, only 7 weeks after EVG mentioned in the final results it expected to take shape in 2025 with $1m payments expected. Huw went to California networking and did conferences here to try and get big pharmas to take on SFX-01 but nothing has come of it. Cash reserves are running lower and lower, must be below £3m cash reserves now. Still no shares bought by anyone connected with the company.
This has been a disaster of a shareholders. £10k invested here in 2018 would be worth just a few hundred quid now. But the employees are doing alright, between them they earned over £1.3m in cash in the last year.
To add to my original comment, Entain really need to do so much better with their betting companies. When you look on Twitter at betting tipsters and anyone showing their betting slips, you literally never see anyone betting with Ladbrokes or Corals. I don’t bet with either and it was Ladbrokes own fault, I once bet on a football match, only £10 and the odds were set wrongly, I got 9/4 on the home team to win whereas everywhere else it was 5/4. The bet went live and had not been cancelled. The home team won and I went online to collect my winnings and only after the match finished they voided the bet and said the odds were wrong. I bet you any money had the home team lost they would not have refunded the money. So I closed my account. Losing a customer for the sake of £10. What if people placed the same bet and Layed the home win on the exchanges, they’d lose loads.
Ladbrokes always has had a feel of being very laddish and targeting the poorer types of people. Coral is pretty much the same. If I was in charge of Entain I’d really focus on improving these betting companies, their image and aim to target more wealthier punters.
I love gambling stocks, I follow Flutter closely, I used to be invested in William hill before it got bought out and also follow 888. I haven’t followed Entain so closely but saw that their share price was around £14 a share. So what’s happened here to see the share price fall so much so quickly.
My own thoughts with Entain is that it is too heavily focused on Britain, Britain is a horrible market for gambling companies, the market is so saturated with dozens of betting companies, the cost of retaining customers with free bets and rewards is high and our nanny state government throw endless obstacles in the bookies way to protect problem gamblers.
But there can be no doubt, gambling will always be popular and there is a global market to tap into. I feel like there is huge potential as a result. Anyone have any good thoughts on why this share price is struggling? I see Flutter and 888 are also falling in recent months. Definitely a sector I want to get back invested into when the time is right.
I’ve got to agree with King Alf. I don’t understand why anyone would be positive about this share unless they are ramping or trying to comfort themselves with this investment. This share was 20p five years ago and is now not much more than 1.5p and yet where is EVG at? They seem as far away as ever from getting SFX-01 to be commercialised to treat diseases/disorders. And when you’ve got only about £3m in cash and the only income being either a share placing and/or the Stalicla deal which we know so little about it’s a major problem.
Proinvestor, you write like one of these liberal lefties believing you are right in your summary of EVG but the share price just like the mess the Europe is in speaks volumes that you’re wrong. If EVG is such a great business and has so much potential please tell us why the share price is at the lowest it’s ever been. EVG could be a good share many years down the line but right now it’s clearly not.
I do hope the rampers are sitting on heavy losses. Rampers need to be called out, they are a disgrace, trying to make people buy into dud shares hoping it will push the price up. They don’t care less if they make people lose money.
Pro investor, I still stick with my comments that SFX-01 has potential, although my confidence has waned somewhat in the last six months, for example why did Juvenesense pull their plug on EVG? My problem with this share is that despite years of work already the company appears to be so far away from securing any commercial deals to see money streaming in. They have said themselves they are hoping to find larger pharmas to form partnerships with to do clinical trials but no news of that happening this year. .
Look at the Stalicla deal, 13 months down the line and only $500k received so far. There is such a cloud of uncertainty of when next payments will be received, originally it was supposed to be by the end of 2023.
My whole problem with EVG is that only has such short term funding. Even if they get $5.5m from Stalicla that will only last one year. A share dilution at this share price wipes out any chance anyone can make money from investing here and given you agree it’s a high risk investment that is a massive problem.
I am not deramping looking to buy in cheaper. I would only buy in if there was news of some great deal with a guaranteed income stream.
I was looking over past comments here to see who was critical of mine and Alf’s comments here over recent months. It struck me that some posters were critical of my opinions because they said that EVG’s mission to help treat cancers and other illnesses, disorders and diseases meant it was wrong to be critical.
Can I ask, have I made a mistake - did people here buy EVG shares as they wanted to help fund a company that are doing good rather than it being an investment? That’s really commendable of people if that is the case, that’s like donating thousands to charity and I really am genuinely sorry for being critical of you if you bought shares as a charitable gesture. It’s no wonder we clashed as I’ll be honest, I invested hoping to make money.
I was thinking I wonder if the rampers who were critical of the de rampers in recent weeks would like to apologise for the negative comments posted towards us? We weren’t saying our comments to be trolls but because we could see what was coming.
I’d certainly appreciate an apology as I’m sure others would too.
Share price has to return to the 450s, Aviva’s share price tumbled due to the markets, worries of inflation and cost of living crisis that may effect revenue. But Aviva have been solid, they always will be. The share price should return to where it deserves to be.
I tried telling the rampers after the RNS on Friday that this had to keep falling. Did they listen? No. They said keep buying, it’s a bargain and my fav “the MMs don’t have enough shares” even though 150m will be issued.
I tried telling them that their deluded claims that this will get to 2.5p by end of Monday, that one clown dared shorters to short was delusional. You all saw that didn’t you? I’ve tried to help these people but they throw it in my face. What planet are these clowns living on? I really believe these rampers put on clown costumes, big perm wig and big clown shoes when they get out of bed. Be careful investing here people, it’s a dog of a share.
Huw went to California in the summer to network and tout for business but clearly nothing came if it.
These rampers who claim it would be 2.5p by end of day, they dare the shorters to sell, thinking a share placing to dilute the shares in half for a pathetic £600k is a great thing.
Beware of these pathetic people, they are clearly just teenagers who are so full of it. This is a dog of a share.